Attached files
file | filename |
---|---|
EX-12 - STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES - ELI LILLY & Co | lly-20151231x10kexhibit12.htm |
EX-32 - SECTION 1350 CERTIFICATION - ELI LILLY & Co | lly-20151231x10kexhibit32.htm |
EX-21 - LIST OF SUBSIDIARIES AND AFFILIATES - ELI LILLY & Co | lly-20151231x10kexhibit21.htm |
EX-31.1 - RULE 13A-14(A) CERTIFICATION OF JOHN C. LECHLEITER, PH.D., CHAIRMAN OF THE BOARD - ELI LILLY & Co | lly-20151231x10kexhibit311.htm |
EX-31.2 - RULE 13A-14(A) CERTIFICATION OF DERICA W. RICE, EXECUTIVE VICE PRESIDENT, GLOBAL - ELI LILLY & Co | lly-20151231x10kexhibit312.htm |
10-K - 10-K - ELI LILLY & Co | lly-20151231x10k.htm |
EX-10.3 - ELI LILLY AND COMPANY SHAREHOLDER VALUE AWARD (FOR EXECUTIVE OFFICERS) - ELI LILLY & Co | lly-20151231x10kexhibit103.htm |
Exhibit 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3ASR No. 333-186979; and Form S-8 Nos. 333-104057 and 333-172422) of Eli Lilly and Company and subsidiaries and in the related Prospectus of our reports dated February 19, 2016, with respect to the consolidated financial statements of Eli Lilly and Company and subsidiaries, and the effectiveness of internal control over financial reporting of Eli Lilly and Company and subsidiaries, included in this Annual Report (Form 10-K) for the year ended December 31, 2015.
/s/ Ernst and Young LLP
Indianapolis, Indiana
February 19, 2016